Fractionation is a procedure referred to as the segregation of a certain quantity of a mixture. Moreover, plasma is the fluid element of blood, separated to attain different plasma derivatives, including albumin and immunoglobulins. These obtained plasma products have remedial effects and are used to treat several disorders associated with blood plasma. The rising population of older people worldwide is resulting in several rare diseases that needed plasma derivatives, which is the key aspect that fuels the plasma fractionation market growth. Moreover, an increase in the usage of immunoglobulins and alpha-1-antitrypsin in medical fields worldwide also drives the plasma fractionation market's development. But somehow, enormous costs and minimum reimbursements in this field are likely to hamper the plasma fractionation market growth. The Plasma Fractionation Market will grow at the rate of 6.8% CAGR by 2026.

Research Methodology:

The Plasma Fractionation market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Plasma Fractionation Market by Product

• Immunoglobulins
• Intravenous Immunoglobulins
• Subcutaneous Immunoglobulins
• Other Immunoglobulins
• Coagulation Factor Concentrates
• Factor VIII
• Factor IX
• Von Willebrand Factor
• Prothrombin Complex Concentrate
• Fibrinogen Concentrates
• Factor XIII
• Albumin
• Protease Inhibitors
• Other Products

Plasma Fractionation Market by Application

• Hematology
• Immunology
• Neurology
• Critical care
• Pulmonology
• Hemato-oncology
• Rheumatology
• Other Applications

Plasma Fractionation Market by End User

• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutes 

Plasma Fractionation Market by Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the product, the immunoglobulins segment is happening to hold a significant share in the plasma fractionation market. This segment growth is ascribed to immunoglobulins' different uses in several disorders, including primary and secondary immune deficiencies and inflammatory diseases. Globally, an increase in the R&D associated with immunology is another factor boosting the demand for immunoglobulins.

In terms of application, the plasma fractionation applications consist of hematology, immunology, neurology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. The neurology segment is registered the maximum share in the market due to intravenous immunoglobulin in less time than steroids and its efficacy on several peripheral and central nervous system disorders.

The plasma fractionation market's end-users are hospitals and clinics, clinical research laboratories, and academic institutes. The significant end-users of plasma fractionation are hospitals and clinics. Hospitals require plasma products to treat acute diseases, and the increasing number of patients in hospitals is the reason for fueling the demand for plasma fractionation.

The North American region is leading the plasma fractionation market share during the forecast period. This is due to well-developed healthcare facilities, beneficial government regulations, and rising research and development in plasma fractionation are the factors responsible for the enormous expansion of the market in this region.

Immunoglobulins are employed as the primary remedy for several neurologic, immunologic and hematologic conditions. The most usual immunoglobulin therapy usage is to treat primary immune deficiencies and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The diagnosis percentage of several immunological diseases has increased over the past few years due to technological advancements. Besides, globally increasing genetic research for identifying and diagnosing immunodeficiency will surge in the clinical requirement for immunoglobulins, increasing the global plasma fractionation market growth.

The profiles of companies leading the plasma fractionation market include Bharat Serums and Vaccines Limited, Shanghai RAAS Blood Products, Japan Blood Products Organization, Green Cross Corporation, Grifols, Shire, Octapharma, LFB, Biotest, CSL, Sanquin, China Biologic Products, Bio Products Laboratory, Kedrion, Emergent BioSolutions and Intas Biopharmaceuticals.

As a result, plasma fractionation is a vital class of remedies often utilized as the only choice available to prevent, manage, and treat fatal health conditions such as trauma, hereditary deficiencies, immunologic disorders, or infections.

• This report delivers a comprehensive analysis of the plasma fractionation market growth drivers, restraints, opportunities, and other related challenges.
• This report depicts the market developments such as new product launches, mergers and acquisitions, diversification, and joint ventures of the market players.
• This report also describes all potential segments and sub-segments present in the market to help the companies in strategic business planning.

This report also gives the regional analysis of the plasma fractionation market in terms of market penetration across the world.

1. Executive Summary
2. Industry Outlook
   1. Industry Overview
   2. Industry Trends
3. Market Snapshot
   1. Market Definition
   2. Market Outlook
      1. PEST Analysis
      2. Porter Five Forces
   3. Related Markets
4. Market characteristics
   1. Market Evolution
   2. Market Trends and Impact
   3. Advantages/Disadvantages of Market
   4. Regulatory Impact
   5. Market Offerings
   6. Market Segmentation
   7. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
   8. DRO - Impact Analysis
5. Product: Market Size & Analysis
   1. Overview
   2. Immunoglobulins
   3. Intravenous Immunoglobulins
   4. Subcutaneous Immunoglobulins
   5. Other Immunoglobulins
   6. Coagulation Factor Concentrates
   7. Factor VIII
   8. Factor IX
   9. Von Willebrand Factor
   10. Prothrombin Complex Concentrate
   11. Fibrinogen Concentrates
   12. Factor XIII
   13. Albumin
   14. Protease Inhibitors
   15. Other Products
6.  Application: Market Size & Analysis
   1. Overview
   2. Hematology
   3. Immunology
   4. Neurology
   5. Critical care
   6. Pulmonology
   7. Hemato-oncology
   8. Rheumatology
   9. Other Applications
7. End-User: Market Size & Analysis
   1. Overview
   2. Hospitals & Clinics
   3. Clinical Research Laboratories
   4. Academic Institutes
8. Geography: Market Size & Analysis
   1. Overview
   2. North America
   3. Europe
   4. Asia Pacific
   5. Rest of the World
9. Competitive Landscape
   1. Competitor Comparison Analysis
   2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
10. Vendor Profiles
    1. Bharat Serums and Vaccines Limited
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    2. Shanghai RAAS Blood Products
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    3. Japan Blood Products Organization
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    4. Green Cross Corporation
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    5. Grifols
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    6. Shire
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    7. Octapharma
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    8. LFB
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    9. Biotest
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    10. CSL
        1. Overview
        2. Financial Overview
        3. Product Offerings
        4. Developments
        5. Business Strategy
11. Companies to Watch
    1. Sanquin
       1. Overview
       2. Market
       3. Business Strategy
    2. China Biologic Products
       1. Overview
       2. Market
       3. Business Strategy
    3. Bio Products Laboratory
       1. Overview
       2. Market
       3. Business Strategy
    4. Kedrion
       1. Overview
       2. Market
       3. Business Strategy
    5. Emergent BioSolutions
       1. Overview
       2. Market
       3. Business Strategy
    6. Intas Biopharmaceuticals
       1. Overview
       2. Market
       3. Business Strategy
12. Analyst Opinion
13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
       1. Data Collation and In-house Estimation
       2. Market Triangulation
       3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations